Genetic Technologies Ltd has released a press release.
Q4 FY22 Results Milestones and Growth
Filed with ASX ·
6ix hasn’t read this filing yet.
Genetic Technologies Limited on 6ix
Earlier from Genetic Technologies
- GeneType Risk Test Implemented in 9 Siles Health Clinics
- Completion of AffinityDNA Acquisition
- EasyDNA Expands Indian and European Markets
- GeneType Risk Assessment Test Onboarding in 16 clinics
- Transformational Pathway to US Payer System
Later from Genetic Technologies
- Annual Report to Shareholders and Appendix 4E
- GTG Building Momentum on Commercial Plans
- GeneType Outperforms Traditional Risk Assessments
- Genetype for Ovarian Cancer published in European Journal
- AGM Presentation and Chairmans Address
Follow Genetic Technologies into a list and get an email when it puts out news.
Follow Genetic Technologies